Dear CDI Team Members, Partners, and Customers, 2024 was another transformative year for CDI. It was a year that tested our resilience, celebrated our innovation, and reinforced our unwavering commitment to improving lives through advanced diagnostic solutions. This past year, we tested our limits, sharpened our focus, and reaffirmed our commitment to the community of…
We are excited to announce that Commonwealth Diagnostics International (CDI) is now an approved System for Award Management (SAM.gov) vendor. With our assigned CAGE Code 80GK2, CDI is officially recognized as a trusted partner in the U.S. government procurement system, streamlining our ability to collaborate with federal agencies and deliver diagnostic solutions efficiently. The SAM.gov…
SALEM, Mass. — Commonwealth Diagnostics International (CDI) proudly announces a new in-network agreement with Premera Blue Cross, expanding access to our hydrogen and methane breath testing for over 2.8 million lives in Washington State and Alaska. This latest agreement underscores CDI’s commitment to enhancing the accessibility and affordability of breath testing for SIBO, IMO, and…
At Commonwealth Diagnostics International (CDI), we are dedicated to enhancing patient experiences and improving the ease and efficiency of our hydrogen and methane breath testing process. We are excited to announce the launch of new instructional videos and translated patient guides in six languages: Spanish, Russian, Hmong, Vietnamese, Somali, and Karen. These resources are designed…
SALEM, Mass. — Commonwealth Diagnostics International (CDI) is excited to share the benefits of our new in-network status with CareFirst BlueCross BlueShield and CareFirst BlueChoice, the most extensive not-for-profit health plan in the Mid-Atlantic. This partnership, covering over 3.5 million individuals and groups in Maryland, the Washington D.C. metropolitan area, and parts of Virginia, significantly enhances…
SALEM, Mass. — Commonwealth Diagnostics International, Inc. (CDI), The Leader in Hydrogen and Methane Breath Testing®, is now in-network with Blue Cross and Blue Shield of Illinois (BCBSIL), the state’s largest health insurance company. This significant development is part of CDI’s ongoing efforts to enhance accessibility to its clinically validated non-invasive at-home breath tests for…
CDI is proud to announce the launch of our new hydrogen and methane breath test kit registration process, designed to optimize the testing experience for healthcare providers and their patients. This streamlined process ensures that patients receive personalized support, enhancing the accuracy and efficiency of test results. Here’s how it simplifies the process for your…
Dear CDI Team Members, Healthcare Partners, and Industry Stakeholders: As we reflect on our past year, we can see clearly staring back at us a period marked by growth, resilience, innovation, and impact. This year, CDI has not just navigated but thrived in a complex and evolving healthcare environment. Our dedication to enhancing the quality…
MyGI Gateway will transform hydrogen and methane breath testing with streamlined kit registration, advanced patient engagement, and analytics throughout the diagnostic process. SALEM, Mass. – October 20, 2023 – Commonwealth Diagnostics International, Inc. (CDI), The Leader In Hydrogen and Methane Breath Testing®, is excited to announce the launch of MyGI Gateway™, a cutting-edge cloud-based provider…
As the Leader in Hydrogen and Methane Breath Testing, CDI follows industry best practices and stays current with the latest industry research to provide its patients with the best test taking experience. As such, we are pleased to announce updates to all our breath test Instructions for Use (IFUs), including an expanded list of permitted…
